Cholinergic Receptor, Muscarinic 2 (CHRM2) Peptid
Kurzübersicht für Cholinergic Receptor, Muscarinic 2 (CHRM2) Peptid (ABIN7235118)
Target
Quelle
Applikation
-
-
Verwendungszweck
- CHRM2 Negative Control Antigen
-
Sequenz
- GST fusion protein with the sequence VANQDPVSPS LVQGRIVKPN NNNMPSSDDG LEHNKIQNGK APRDPVTENC VQGEEKESSN DSTSV SAVASNMRDD EITQDENTVS TSLGHSKDEN SKQTCIRIGT KTPKS DSCTPTNTTV EVVGSSGQNG DE, correspond ing to amino acid residues 225-356 of human M2 (Accession P08172).
-
Produktmerkmale
- GST fusion protein, A Blocking peptide for Anti-CHRM2 Antibody (ABIN7043062, ABIN7044582 and ABIN7044583). Intended to be used as a negative control.
-
Reinheit
- >95 % (SDS-PAGE)
-
-
-
-
Applikationshinweise
- Antigen Preadsorption Control: 3 μg fusion protein per 1 μg antibody.
-
Kommentare
-
Confirmed by DNA sequence and SDSPAGE.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- 100 μL PBS.
-
Konzentration
- 0.4 mg/mL
-
Lagerung
- RT,-20 °C
-
Informationen zur Lagerung
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
-
- Muscarinic Acetylcholine Receptor M2 (CHRM2) (Cholinergic Receptor, Muscarinic 2 (CHRM2))
-
Gen-ID
- 1129
Target
-